Open Targets
Open Targets
Evidence linking genes to diseases, ranked to help prioritize drug targets.
The Open Targets Platform integrates public genetics, genomics, drug, pathway, and literature evidence to score how strongly a gene or protein is associated with a disease. Released every three months. Used to build and test therapeutic hypotheses.
Access
- Cost
- FreeNo charge to download; hosted in an AWS S3 bucket.
- License
- Public domainCC0 1.0
- Sign-up
- No sign-up
- How you get it
- API and Bulk downloadParquet, JSON
What's in it
- One row is
- One association or evidence record per target-disease pair
- Covers
- Not geographic
- Years
- Not stated
- Updated
- Quarterly
- Size
- Not stated
Quality
Systematic, well documented, and regularly released with versioned snapshots. Scores reflect available evidence, not proven causation.
- Scores reflect evidence volume
- Large Parquet releases
Connects to
- Genome Aggregation Database (gnomAD): Constraint and variant frequency information per gene
- CIViC (Clinical Interpretation of Variants in Cancer): Curated cancer variant evidence that complements target evidence
Questions it could answer
- Which targets have genetic evidence but no approved drug?
- How do association scores change between releases?